I think I saw that the cash would last until early 2016 as well. Sometime between now and then, there be maybe more cash coming in from a partnership deal or product sales.
I do not know when the filter will become standard of care but know that numerous times, Dr Chan talks about doctors helping to get data out so that CytoSorb can be part of the standard of care in certain areas. Dr Born was on a video talking about CytoSorb as SOC in cardiac surgery. In addition, Dr Steiner is experienced in introducing new technologies into the ICU starting with MARS, the most used extracorporeal liver support system in ICU patients with liver failure today...I think within 10 years. MARS was at that time was a completely new blood purification technology out of the University of Rostock. As you have seen pictures of Dr Steiner, he's pretty young. Dr Steiner said interest in CytoSorb was far greater than any product he was involved with. Remember at the Brussels Cytosorb lunch symposium this year, they could not fit enough people in the room. It was standing room, and people kept coming in, so some had to leave because they were was no room for them.
From a PR about Dr Steiner's hire:
Dr. Steiner continued, "Based upon my experience in introducing many new critical care products, including MARS™ and PiCCO®, the interest in CytoSorb® is real and far greater than any product I have been involved with before. Although launching any new medical product is challenging and requires hard work, I firmly believe that CytoSorb® has the right combination of characteristics to make it a potential major success. In addition, our outstanding initial veteran sales team knows this space well, understands the technology, and has the network of key opinion leaders nationally and internationally to catalyze adoption and early market development. I am proud to be part of bringing a therapy to market that could potentially help many people."
